Skip to content

Does Latuda Cause Tremors? Understanding Extrapyramidal Symptoms

4 min read

In clinical studies, a significant number of people taking Latuda (lurasidone) experienced extrapyramidal symptoms (EPS), a group of movement problems that can include muscle tremor. This indicates a clear and documented link confirming the answer to: Does Latuda cause tremors? Yes, it is a known side effect.

Quick Summary

Latuda (lurasidone), an atypical antipsychotic, can cause tremors and other movement problems, collectively known as extrapyramidal symptoms (EPS). The risk is related to its mechanism of action, which affects dopamine receptors. Management options for this side effect involve dose adjustment or medication changes under a doctor's supervision.

Key Points

  • Known Side Effect: Latuda can cause tremors as part of a group of movement disorders called extrapyramidal symptoms (EPS).

  • EPS Manifestations: EPS can also include akathisia (restlessness), parkinsonism (stiffness, slow movement), and tardive dyskinesia (involuntary facial movements).

  • Dopamine Link: Tremors from Latuda are linked to its mechanism of action, which involves blocking dopamine receptors in the brain.

  • Professional Guidance: Do not stop Latuda abruptly if you experience tremors, as withdrawal can occur. Consult your doctor for a managed approach.

  • Management Options: Treatment for tremors may include dose reduction, switching to an alternative medication, or adding another drug like an anticholinergic.

  • Early Detection: Report any new or unusual movements to your healthcare provider promptly to address the issue before it worsens.

In This Article

What are Latuda-induced tremors?

Latuda (lurasidone) is a medication prescribed for schizophrenia and bipolar depression. Like other antipsychotics, it works by rebalancing neurotransmitters like dopamine and serotonin in the brain to improve mood and behavior. However, this rebalancing can sometimes lead to unwanted motor side effects, known as extrapyramidal symptoms (EPS). A tremor, or uncontrollable shaking, is one such symptom and is often described as a shaking in the legs, arms, hands, or feet.

Experiencing a tremor while on Latuda can be distressing and feel similar to the symptoms of Parkinson's disease, a condition known as drug-induced parkinsonism. It is crucial for patients to recognize these symptoms and report them to their healthcare provider for proper evaluation and management.

The link between Latuda and extrapyramidal symptoms (EPS)

EPS are a group of involuntary movement disorders that can arise from medications that affect the brain's dopamine pathways. Latuda, specifically, exerts its antipsychotic effects by blocking dopamine D2 receptors. While effective for its intended purpose, this blockade can interfere with the brain's motor control systems, leading to EPS.

Types of EPS caused by Latuda

While tremor is a specific symptom, it's often accompanied by or confused with other types of EPS. The most common EPS associated with Latuda include:

  • Parkinsonism: A syndrome resembling Parkinson's disease, characterized by muscle stiffness, slowed movement, and tremor.
  • Akathisia: A sense of uncomfortable inner restlessness and an urgent need to move. Patients may fidget, pace, or shift their weight constantly. Akathisia was a particularly common side effect reported in clinical trials.
  • Dystonia: Sustained or repetitive muscle contractions that result in twisting and abnormal postures. It can affect the neck, tongue, face, or back.
  • Tardive Dyskinesia (TD): A potentially irreversible movement disorder that can develop after long-term use of antipsychotics. It is characterized by involuntary, repetitive facial movements, such as grimacing, chewing, or tongue movements. Latuda is associated with a lower risk of TD compared to older antipsychotics, but the risk increases with higher doses and longer duration of use.

Distinguishing Latuda-induced tremors from other movement disorders

To receive appropriate management, it is helpful to understand the differences between the EPS caused by Latuda. While all are movement-related, their symptoms and character can vary.

Feature Latuda-Induced Tremor (Parkinsonism) Akathisia Tardive Dyskinesia (TD)
Primary Symptom Rhythmic, involuntary shaking. Inner sense of restlessness and need to move. Involuntary, repetitive movements, often in the face or tongue.
Symptom Character Often occurs at rest, but can also be an 'action tremor'. Not a tremor, but a feeling of unease and motor restlessness. Can involve writhing, jerking, or smacking motions.
Patient Experience Feels like shaking hands or limbs, muscle stiffness, shuffling walk. Feels like an intense compulsion to pace or constantly move. Patient may not be aware of the movements; less internal compulsion.
Typical Onset Within days to weeks of starting Latuda or increasing the dose. Can occur early in treatment, often within weeks. Develops with prolonged use of antipsychotics, can appear after stopping.
Management Dose reduction or addition of anticholinergic medication. Dose reduction, change in medication, or beta-blocker. Changing medication, though TD may be irreversible.

Managing and treating Latuda-induced tremors

If you experience tremors or other EPS, do not stop taking Latuda suddenly. Abrupt discontinuation can lead to withdrawal symptoms and a relapse of the underlying condition. Instead, work with your healthcare provider to find the best course of action.

Medical interventions

  • Dosage Adjustment: Your doctor may decrease your Latuda dose to reduce the severity of the tremors.
  • Medication Change: Switching to a different antipsychotic with a lower propensity for causing EPS might be considered.
  • Symptomatic Treatment: Your doctor might prescribe a short-term course of an anticholinergic medication, such as benztropine or trihexyphenidyl, to alleviate the tremors and other parkinsonism symptoms. A beta-blocker like propranolol may also be used to help control the shaking.

Lifestyle and behavioral strategies

  • Stress Management: Stress and anxiety can exacerbate tremors. Incorporating relaxation techniques, mindfulness, or light exercise can be beneficial.
  • Exercise: Regular physical activity can help manage overall muscle control and reduce the severity of motor symptoms.

What to do if you experience tremors

If you notice new or unusual muscle movements, including tremors, while taking Latuda, contact your healthcare provider immediately. They can evaluate your symptoms to determine if they are related to the medication and distinguish them from other conditions like akathisia or tardive dyskinesia. Early intervention is key to managing these side effects effectively and preventing them from worsening.

Conclusion

While an effective treatment for schizophrenia and bipolar depression, Latuda can and does cause tremors, along with other extrapyramidal symptoms. The likelihood of developing these motor side effects is well-documented in clinical studies. For individuals experiencing tremors, it is critical to consult with a healthcare professional before making any changes to medication. Through a combination of dose adjustments, additional medications, and supportive care, Latuda-induced tremors can often be effectively managed. The emergence of these symptoms is a signal for a re-evaluation of the treatment plan, not a reason to stop therapy without guidance from a doctor.

For more information on the side effects of lurasidone, consult with a trusted medical resource like the National Alliance on Mental Illness (NAMI): https://www.nami.org/about-mental-illness/treatments/mental-health-medications/types-of-medication/lurasidone-latuda/.

Frequently Asked Questions

Yes, Latuda (lurasidone) can cause tremors, which often manifest as shaking in the hands, arms, feet, and legs. This is a common extrapyramidal symptom (EPS) associated with the medication.

A tremor is an involuntary, rhythmic shaking, while akathisia is an internal feeling of restlessness or an intense urge to move. Akathisia was a more common side effect than tremor in Latuda clinical trials, but both are types of extrapyramidal symptoms.

The onset of tremors and other EPS can vary. They can begin shortly after starting the medication, or soon after a dose increase, sometimes within days or weeks of treatment.

Often, drug-induced tremors will decrease or resolve after discontinuing the offending medication, but this can take time. It is crucial to taper the medication under a doctor's supervision to avoid withdrawal symptoms.

Yes, other abnormal movements linked to Latuda include muscle stiffness and slow movements (parkinsonism), inner restlessness (akathisia), and potentially permanent involuntary facial movements (tardive dyskinesia) with long-term use.

Treatment options include adjusting the Latuda dosage, switching to an alternative medication, or adding another drug to manage the tremors. Sometimes, short-term anticholinergic medications like benztropine are prescribed.

Yes, the risk of developing extrapyramidal symptoms, including tremors, is often linked to the dosage. Higher doses can increase the likelihood and severity of these movement-related side effects.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.